论文部分内容阅读
Dapagliflozin (DAP) is a potent and selective sodium-glucose contransporter-2 (SGLT-2) inhibitor,and performed as an efficacious treatment for type 2 diabetes.Sever hygroscopicity of DAP hinder the usage of its free form during process of pharmaceutical production.